Pancreatic Cancer Research

ResearcherNational Health Research InstitutesActive in the last 2 years

Siao Muk Cheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8145-4220; OpenAlex author ID A5067555231. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC. Co-author DOI 10.1158/1078-0432.ccr-25-4564↗
  2. Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells. Co-author DOI 10.1186/s12943-024-02207-4↗
  3. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan. Co-author DOI 10.1186/s12929-024-01008-7↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yung‐Yeh Su · 3 shared papers, 2024–2026 · strength 0.63
  2. Yan‐Shen Shan · 3 shared papers, 2024–2026 · strength 0.63
  3. Ya‐Chin Hou · 2 shared papers, 2025–2026 · strength 0.46
  4. Nai‐Jung Chiang · 2 shared papers, 2024–2026 · strength 0.41
  5. Ying‐Jui Chao · 2 shared papers, 2024–2026 · strength 0.41
  6. Li‐Tzong Chen · 2 shared papers, 2024–2026 · strength 0.41
  7. Hui‐Jen Tsai · 2 shared papers, 2024–2026 · strength 0.41
  8. Chia‐Ming Yeh · 1 shared paper, 2026 · strength 0.24
  9. Chuan Wang · 1 shared paper, 2025 · strength 0.22
  10. Shaw‐Jenq Tsai · 1 shared paper, 2025 · strength 0.22
  11. Chien‐Jui Huang · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.